NCT05031845View on ClinicalTrials.gov

Low-Dose Chest CT (LDCT) COVID-19 Study

CompletedOBSERVATIONAL
Enrollment

121

Participants

Timeline

Start Date

March 8, 2021

Primary Completion Date

December 30, 2021

Study Completion Date

December 30, 2021

Conditions
Covid19
Trial Locations (1)

20852

Kaiser Permanente Mid-Atlantic States Mid-Atlantic Permanente Research Institute, Rockville

All Listed Sponsors
collaborator

Garfield Memorial Fund

OTHER

lead

Kaiser Permanente

OTHER

NCT05031845 - Low-Dose Chest CT (LDCT) COVID-19 Study | Biotech Hunter | Biotech Hunter